Subcutaneous recombinant hirudin (HBW 023) versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: A multicentre prospective dose-ranging randomized trial

Thrombosis and Haemostasis

Volumn 77, Issue 5, 1997, Pages 834-838

  Schiele, François ^a   Lindgaerde, Folke ^c   Eriksson, Henry ^d   Bassand, Jean Pierre ^a   Wallmark, Anders ^c   Hansson, Per Olaf ^d   Grollier, Gilles ^b   Sjo, Malvin ^e   Moia, Marco ^f   Camez, Anne ^g   Smyth, Vince ^h   Walker, Michael ^h  

^a HÔPITAL SAINT JACQUES   (France)

^b CHU CÔTE DE NACRE   (France)

^c Malmö Almanna Syukhus   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e Regionsykehuset i Tromsø   (Norway)

^f FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^g Laboratoires Hoechst Marion R   (France)

^h MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LEPIRUDIN;

ADULT; AGED; ARTICLE; BLEEDING; BODY WEIGHT; CARDIOPULMONARY INSUFFICIENCY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOSE CALCULATION; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; FEMALE; HEMATOMA; HEMATURIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHLEBOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCINTISCANNING; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA; THROMBUS;

EID: 0030916929     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1656063     Document Type: Article

References (25)

1. Stein PD, Henry JW, Gottschalk A. The addition of clinical assessment to stratification according to prior cardiopulmonary disease further optimizes the interpretation of ventilation/perfusion scans in pulmonary embolism. Chest 1993; 104: 1472-6.
2. The PIOPED Investigators. Value of the ventilation/perfusion lung scan in acute pulmonary embolism. JAMA 1990; 263: 2753-9.
3. Lensing AWA, van Beek EJR, Demers C, Tiel-van Buul MMC, Yakemchuk V, van Dongen A, Coates G, Ginsberg JS, Hirsh J, Wouter ten Cate J, Buller HR. Ventilation-perfusion lung scanning and the diagnosis of pulmonary embolism: improvement of observer agreement by the use of a lung segment chart. Thromb Haemost 1992; 68: 245-9.
4. Walker MG, Shaw JW, Thomson GJL, Cumming JGR, Thomas ML. Subcutaneous calcium heparin versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective randomised trial. Br Med J 1987; 294: 1189-92.
5. Albada J, Nieuwenhuis HK, Sixma JJ. Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin): results of a double-blind randomized study. Circ 1989; 80: 935-40.
6. Hull RD, Raskob GE, Hirsh J, Jay RM, Leclerc JR, Geerts WH, Rosenbloom D, Sackett DL, Anderson C, Harrison L, Gent M. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal vein thrombosis. N Engl J Med 1986; 315: 1109-14.
7. Holm HA, Finnager B, Hartmann A, Laerum F, Lohren O, Ruud TE, Stray N, Wolland T. Heparin treatment of deep venous thrombosis in 280 patients: symptoms related to dosage. Acta Med Scand 1984; 215: 47-53.
8. Hull RD, Raskob GE, Rosenbloom D, Panju AA, Brill-Edwards P, Ginsberg JS, Hirsh J, Martin GJ, Green D. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med 1990; 322: 1260-4.
9. Gallus A, Jackaman J, Tillett J, Mills W, Wycherley A. Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism. Lancet 1986; Dec 6: 1293-6.
10. Weinmann EE, Salzman EW. Deep-vein thrombosis. N Engl J Med 1994; 331: 1630-40.
11. Holm HA, Abildgaard U, Kalvenes S, Anderssen N, Anker E, Arnesen K-E, Blikom D, Drivenes A. The antithrombotic effect of heparin in deep venous thrombosis: relation to four heparin assays. Acta Med Scand 1984; 216: 287-93.
12. Aster RH. Heparin-induced thrombocytopenia and thrombosis. N Engl J Med 1995; 332: 1374-6.
13. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330-5.
14. Stringer KA, Lindenfield J. Hirudins: antithrombin anticoagulants. Ann Pharmacother 1992; 26: 1535-40.
15. Mirshahi M, Soria J, Soria C, Faivre R, Lu H, Courtney M, Roitsch C, Tripier D, Caen JP. Evaluation of the inhibition by heparin and hirudin of coagulation activation during r-tPA induced thrombolysis. Blood 1989; 74: 1025-30.
16. Weitz JI, Hudoba M, Massel D, Maraganore J, Hirsh J. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest 1990; 86: 385-91.
17. Parent F, Bridey F, Dreyfus M, Musset D, Grimon G, Duroux P, Meyer D, Simonneau G. Treatment of severe venous thromboembolism with intravenous hirudin (HBW 023): an open pilot study. Thromb Haemost 1993; 70: 386-8.
18. Schiele F, Vuillemenot A, Kramarz P, Kieffer Y, Soria J, Soria C, Camez A, Mirshahi MC, Bassand JP. A pilot study of subcutaneous recombinant hirudin (HBW 023) in the treatment of deep vein thrombosis. Thromb Haemost 1994; 71: 558-62.
19. Doyle DJ, Turpie AGG, Hirsh J, Best C, Kinch D, Levine MN, Gent M. Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep venous thrombosis. Ann Int Med 1987; 107: 441-5.
20. Bentley PG, Kakkar W, Scully MF, MacGregor IR, Webb P, Chan P, Jones N. An objective study of alternative methods of heparin administration. Thromb Res 1980; 18: 177-187.
21. Girard P, Mathieu M, Simonneau G, Petitpretz P, Cerrina J, Herve P, Rosso J, Musset D, Mensch J, Duroux P. Recurrence of pulmonary embolism during anticoagulant treatment: a prospective study. Thorax 1987; 42: 481-6.
22. Miller GAH, Sutton GC, Kerr IH, Gibson RV, Honey M. Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism. Br Med J 1971; 2: 681-4.
23. Lowe GDO, THRIFT Consensus Group. Risks of and prophylaxis for venous thromboembolism in hospital patients. Br Med J 1992; 305: 567-74.
24. Koopman MMW, Prandoni P, Piovella F, Ockelford PA, Tasman Study Group. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular weight heparin administered at home. N Engl J Med 1996; 334: 682-7.
25. Levine M, Gent M, Hirsch J, LeClerc J et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996; 334: 677-81.